Newsbenzinga
Monte Rosa To Receive $37.5M Milestone Payment From Novartis Following Initiation Of Second Phase 2 Trial Of MRT-6160 In Psoriatic Arthritis
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…